SLIT3 was involved in the final model, and previous researches had demonstrated that the suppression of SLIT3 might induce tumor proliferation and invasion in many solid tumors such as ovarian cancer (45), hepatocellular carcinoma (46), thyroid cancer (47), and gastric cancer (48). Here, SLIT3 is linked to ovarian carcinoma.